UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Sexual dysfunction in young women with breast cancer

Supportive care in cancer, 2013, Vol.21 (1), p.271-280

2013

Volltextzugriff (PDF)

Subjective sexual well-being and sexual behavior in young women with breast cancer

Supportive care in cancer, 2013-07, Vol.21 (7), p.1993-2005

2013

Volltextzugriff (PDF)

Efficacy of Sexological Healthcare for People With Chronic Diseases and Physical Disabilities

Journal of sex & marital therapy, 2010-01, Vol.36 (3), p.282-294

2010

Volltextzugriff (PDF)

Efficacy of Sexological Healthcare for People With Chronic Diseases and Physical Disabifities

Journal of sex & marital therapy, 2010-05, Vol.36 (3), p.282

2010

Volltextzugriff (PDF)

RNA-Binding Protein Dnd1 Inhibits MicroRNA Access to Target mRNA

Cell, 2007-12, Vol.131 (7), p.1273-1286

2007

Volltextzugriff (PDF)

Melanoma cells can be eliminated by sialylated CD43 × CD3 bispecific T cell engager formats in vitro and in vivo

Cancer Immunology, Immunotherapy, 2021-06, Vol.70 (6), p.1569-1581

2021

Volltextzugriff (PDF)

Dose-Finding and Pharmacokinetic Study of Cisplatin, Gemcitabine, and SU5416 in Patients With Solid Tumors

Journal of clinical oncology, 2002-03, Vol.20 (6), p.1657-1667

Kuenen, B. C.

2002

Volltextzugriff (PDF)

Presence of crown-like structures in breast adipose tissue; differences between healthy controls, BRCA1/2 gene mutation carriers and breast cancer patients

Breast cancer research and treatment, 2024-02, Vol.204 (1), p.27-37

2024

Volltextzugriff (PDF)

580P AT1412, a patient-derived CD9 antibody promotes tumour immune infiltration and induces tumour rejection

Annals of oncology, 2020-09, Vol.31, p.S492-S492

2020

Volltextzugriff (PDF)

582P Preclinical development of AT1412, a patient derived CD9 antibody that does not induce thrombosis for treatment of precursor B ALL

Annals of oncology, 2020-09, Vol.31, p.S493-S493

2020

Volltextzugriff (PDF)

Abstract 5163: A colon cancer survivor-derived antibody recognizes a previously unidentified truncated, O-mannosylated 70kDa variant of E-cadherin

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.5163-5163

2020

Volltextzugriff (PDF)

Determinants of CPT-11 and SN-38 activities in human lung cancer cells

British journal of cancer, 1998-06, Vol.77 (12), p.2171-2176

1998

Volltextzugriff (PDF)

PO-434 AT1413 antibody derived from a cured AML patient recognisesa unique sialylated CD43 epitope shared by AML, MDS and melanoma cells

ESMO open, 2018-07, Vol.3 (Suppl 2), p.A192-A192

2018

Volltextzugriff (PDF)

Continuous administration of irinotecan by hepatic arterial infusion: A Phase I and pharmacokinetic study

Clinical cancer research, 2002-02, Vol.8 (2), p.405-412

2002

Volltextzugriff (PDF)

Sexuality in Adult Patients With Congenital Heart Disease and Their Partners

The American journal of cardiology, 2010-10, Vol.106 (8), p.1163-1168.e8

2010

Volltextzugriff (PDF)

Donor-Derived B Cells Produce Potent AML-Specific Antibodies That Recognize Novel Tumor-Specific Antigens and Mediate Graft-Versus-Leukemia Immunity

Blood, 2015-12, Vol.126 (23), p.3146-3146

2015

Volltextzugriff (PDF)

PS971 AT1413 ANTIBODY DERIVED FROM A CURED AML PATIENT RECOGNIZES A UNIQUE CD43 EPITOPE SHARED BY AML, MDS AND MELANOMA AND HAS IN VIVO ACTIVITY AS UNMODIFIED ANTIBODY AND AS BISPECIFIC T CELL ENGAGER

HemaSphere, 2019-06, Vol.3 (S1), p.437-438

2019

Volltextzugriff (PDF)

The chemical reactivity of BNP7787 and its metabolite mesna with the cytostatic agent cisplatin: comparison with the nucleophiles thiosulfate, DDTC, glutathione and its disulfide GSSG

Cancer chemotherapy and pharmacology, 2003-06, Vol.51 (6), p.499-504

2003

Volltextzugriff (PDF)

The cardioprotector monoHER does not interfere with the pharmacokinetics or the metabolism of the cardiotoxic agent doxorubicin in mice

Cancer chemotherapy and pharmacology, 2003-04, Vol.51 (4), p.306-310

2003

Volltextzugriff (PDF)

Bioavailability and pharmacokinetics of the cardioprotecting flavonoid 7-monohydroxyethylrutoside in mice

Cancer chemotherapy and pharmacology, 2003-11, Vol.52 (5), p.371-376

2003

Volltextzugriff (PDF)

Continuous Administration of Irinotecan by Hepatic Arterial Infusion

Clinical cancer research, 2002-02, Vol.8 (2), p.405

2002

Volltextzugriff (PDF)

1 – 21 von 21

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(21)

Sprache

Englisch
(21)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Sexual dysfunction in young women with breast cancer

Subjective sexual well-being and sexual behavior in young women with breast cancer

Efficacy of Sexological Healthcare for People With Chronic Diseases and Physical Disabilities

Efficacy of Sexological Healthcare for People With Chronic Diseases and Physical Disabifities

RNA-Binding Protein Dnd1 Inhibits MicroRNA Access to Target mRNA

Melanoma cells can be eliminated by sialylated CD43 × CD3 bispecific T cell engager formats in vitro and in vivo

Dose-Finding and Pharmacokinetic Study of Cisplatin, Gemcitabine, and SU5416 in Patients With Solid Tumors

Presence of crown-like structures in breast adipose tissue; differences between healthy controls, BRCA1/2 gene mutation carriers and breast cancer patients

580P AT1412, a patient-derived CD9 antibody promotes tumour immune infiltration and induces tumour rejection

582P Preclinical development of AT1412, a patient derived CD9 antibody that does not induce thrombosis for treatment of precursor B ALL

Abstract 5163: A colon cancer survivor-derived antibody recognizes a previously unidentified truncated, O-mannosylated 70kDa variant of E-cadherin

Determinants of CPT-11 and SN-38 activities in human lung cancer cells

PO-434 AT1413 antibody derived from a cured AML patient recognisesa unique sialylated CD43 epitope shared by AML, MDS and melanoma cells

Continuous administration of irinotecan by hepatic arterial infusion: A Phase I and pharmacokinetic study

Sexuality in Adult Patients With Congenital Heart Disease and Their Partners

Donor-Derived B Cells Produce Potent AML-Specific Antibodies That Recognize Novel Tumor-Specific Antigens and Mediate Graft-Versus-Leukemia Immunity

PS971 AT1413 ANTIBODY DERIVED FROM A CURED AML PATIENT RECOGNIZES A UNIQUE CD43 EPITOPE SHARED BY AML, MDS AND MELANOMA AND HAS IN VIVO ACTIVITY AS UNMODIFIED ANTIBODY AND AS BISPECIFIC T CELL ENGAGER

The chemical reactivity of BNP7787 and its metabolite mesna with the cytostatic agent cisplatin: comparison with the nucleophiles thiosulfate, DDTC, glutathione and its disulfide GSSG

The cardioprotector monoHER does not interfere with the pharmacokinetics or the metabolism of the cardiotoxic agent doxorubicin in mice

Bioavailability and pharmacokinetics of the cardioprotecting flavonoid 7-monohydroxyethylrutoside in mice

Continuous Administration of Irinotecan by Hepatic Arterial Infusion

Suchergebnisse filtern